2 line items for anti-interleukin monoclonal antibodies for asthma (BENRALIZUMAB). Awarded for a base year of 2/15/2021 to 2/14/2022 plus four one-year option periods.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79721D0007
- Awardee
-
Astrazeneca Pharmaceuticals LP UEI E5K2ZJ8CTJH4
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Subcutaneous Anti-Interleukin Monoclonal Antibodies for Asthma (VA-21-00000590) Pre-Solicitation · 36E79720R0068 · Posted Sep 2, 2020
- 6505--Subcutaneous Anti-Interleukin Monoclonal Antibodies for Asthma/Benralizumab Award Notice · Posted Jan 20, 2021
- 6505--Subcutaneous Anti-Interleukin Monoclonal Antibodies for Asthma (VA-21-00000590) Solicitation · Posted Oct 21, 2020
- Last date to order 100% complete
- IDV ceiling
- $377,812,500.00
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs awarded a single-award Indefinite Delivery Contract valued at $377.8 million to AstraZeneca Pharmaceuticals LP for the procurement and supply of anti-interleukin monoclonal antibodies for asthma treatment. The contract, effective February 15, 2021, through February 14, 2026, comprises a base performance year plus four one-year option periods and was funded through the National Acquisition Center. The solicitation, posted September 2, 2020, specifically targeted the acquisition of benralizumab, mepolizumab, and dupilumab in various dosages and package configurations to serve an estimated combined patient population of approximately 4,650 individuals across the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract utilizes no set-aside designation, reflecting AstraZeneca's capacity as an established pharmaceutical manufacturer to meet complex federal procurement requirements.
The contract mandates uninterrupted supply of subcutaneous anti-interleukin monoclonal antibodies distributed through the VA and Department of Defense Prime Vendor programs, with specific emphasis on benralizumab as indicated in the contract description. The pharmaceutical products are classified under North American Industry Classification System code 325412 and require offerors to specify exact product names and National Drug Code numbers for each antibody variant supplied. These monoclonal antibody therapies address a critical therapeutic need for asthma management across multiple federal healthcare beneficiary populations, with the contract structure enabling flexible ordering and delivery mechanisms through the established indefinite delivery vehicle to ensure consistent medication availability throughout the performance period.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 18
Quick answers
Who was awarded contract 36E79721D0007?
36E79721D0007 was awarded to Astrazeneca Pharmaceuticals LP by National Acquisition Center (Headquarters) on February 15, 2021.
How much is contract 36E79721D0007 worth?
36E79721D0007's own ceiling is $377,812,500.
Who can order from contract 36E79721D0007?
36E79721D0007 is a single award indefinite delivery contract.
Was contract 36E79721D0007 competed?
The extent of competition for 36E79721D0007 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV